Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1980 1
1982 1
1983 4
1989 1
1994 1
2003 2
2004 2
2005 3
2006 1
2007 1
2008 1
2009 1
2010 3
2011 1
2016 1
2018 3
2019 2
2020 1
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective.
Louis E, Ramos-Goñi JM, Cuervo J, Kopylov U, Barreiro-de Acosta M, McCartney S, Rosenfeld G, Bettenworth D, Hart A, Novak K, Donnet X, Easton D, Saldaña R, Protze K, Tzur E, Alperovich G, Casellas F. Louis E, et al. Among authors: alperovich g. Patient. 2020 Jun;13(3):317-325. doi: 10.1007/s40271-019-00407-5. Patient. 2020. PMID: 31997116 Free PMC article.
The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn's disease: a post hoc analysis.
Hyams JS, Dubinsky M, Rosh J, Ruemmele FM, Eichner SF, Maa JF, Lazar A, Alperovich G, Mostafa NM, Robinson AM. Hyams JS, et al. Among authors: alperovich g. Aliment Pharmacol Ther. 2019 Jan;49(2):155-164. doi: 10.1111/apt.15054. Epub 2018 Dec 2. Aliment Pharmacol Ther. 2019. PMID: 30506693 Clinical Trial.
Sirolimus monotherapy as maintenance immunosuppression: a multicenter experience.
Pinto JR, Arellano Torres EM, Franco A, Morales JM, Ruiz JC, Diekmann F, Alperovich G, Campistol JM. Pinto JR, et al. Among authors: alperovich g. Transpl Int. 2010 Mar 1;23(3):307-12. doi: 10.1111/j.1432-2277.2009.00983.x. Epub 2009 Oct 15. Transpl Int. 2010. PMID: 19843293 Free article. Clinical Trial.
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis.
Blauvelt A, Gordon KB, Lee P, Bagel J, Sofen H, Lockshin B, Soliman AM, Geng Z, Zhan T, Alperovich G, Stein Gold L. Blauvelt A, et al. Among authors: alperovich g. J Dermatolog Treat. 2021 May 5:1-9. doi: 10.1080/09546634.2021.1914812. Online ahead of print. J Dermatolog Treat. 2021. PMID: 33947295
Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.
Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C. Papp KA, et al. Among authors: alperovich g. Br J Dermatol. 2021 Dec;185(6):1135-1145. doi: 10.1111/bjd.20595. Epub 2021 Sep 21. Br J Dermatol. 2021. PMID: 34157132
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial.
Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Alperovich G, Lu W, Wang Z, Soliman AM, Eldred A, Barcomb L, Kivitz A. Östör A, et al. Among authors: alperovich g. Ann Rheum Dis. 2021 Nov 23:annrheumdis-2021-221048. doi: 10.1136/annrheumdis-2021-221048. Online ahead of print. Ann Rheum Dis. 2021. PMID: 34815219 Free article.
Long-term graft function changes in kidney transplant recipients.
Marcén R, Morales JM, Fernández-Rodriguez A, Capdevila L, Pallardó L, Plaza JJ, Cubero JJ, Puig JM, Sanchez-Fructuoso A, Arias M, Alperovich G, Serón D. Marcén R, et al. Among authors: alperovich g. NDT Plus. 2010 Jun;3(Suppl_2):ii2-ii8. doi: 10.1093/ndtplus/sfq063. NDT Plus. 2010. PMID: 20508857 Free PMC article.
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry.
DʼHaens G, Reinisch W, Panaccione R, Satsangi J, Petersson J, Bereswill M, Arikan D, Perotti E, Robinson AM, Kalabic J, Alperovich G, Thakkar R, Loftus EV. DʼHaens G, et al. Among authors: alperovich g. Am J Gastroenterol. 2018 Jun;113(6):872-882. doi: 10.1038/s41395-018-0098-4. Epub 2018 Jun 5. Am J Gastroenterol. 2018. PMID: 29867173
31 results